Vox Markets Podcast
Welcome to the The Vox Markets Podcast. Each episode features interviews with CEOs, sector specialists, research analysts and investment experts.
Share:
Neil Clark, CEO of Destiny Pharma, explains the significance of new data for NTCD-M3, its novel treatment for the prevention of C. difficile infection
26th Jul 2022 13:12
0
See more in series
0